Palliative and end-of-life care for patients with pleural mesothelioma: A cohort study

Palliat Med. 2025 Feb;39(2):286-297. doi: 10.1177/02692163241302454. Epub 2024 Dec 17.

Abstract

Background: Pleural mesothelioma is a rare and incurable cancer, with complex physical and psychological symptoms. Despite recent advances in treatment, prognosis remains poor (average 8-15 months) with a lack of research on palliative and end-of-life care.

Aim: To examine markers suggestive of quality palliative and end-of-life care, including receipt of specialist palliative care, advance care planning, fewer unplanned hospital admissions at end-of-life. To compare variables with socio-economic position to identify if inequalities exist.

Design: A cohort study, retrospectively reviewing the medical notes from diagnosis to death for all patients diagnosed with pleural mesothelioma between 01/01/2016 and 31/12/2021.

Setting/participants: Over 5 years, n = 181 patients were diagnosed with pleural mesothelioma across Teesside (north-east England), n = 30 were alive at study commencement and excluded. For the 151-patient cohort, demographics were as follows: 92% male, 79% aged 70-89 years and 26% in the lowest socio-economic quintile (based on area-level deprivation).

Results: Median survival was 246 days. Within the final 90 days of life, 69% of patients had at least 1 unplanned hospital admission, with 20% having 3+ (range 0-7). Those with the highest socio-economic position had less admissions on average. Specialist palliative care was received by patients, at home 34%, in hospital 26%, in hospice 11%. Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions, were in the final 24 h of life for 18% of patients (median 7 days). Disease specific findings included police attendance for expected deaths and lack of signposting.

Conclusion: Patients with pleural mesothelioma have unplanned admissions to hospital towards the end of life, with possible inequalities; they receive late advance care planning and face challenges unique to their disease. It is important that patients receive high quality palliative end-of-life care through accessing specialist palliative care or have guidance/signposting to other potential sources of support.

Keywords: Mesothelioma; advance care planning; coroner; delivery of healthcare; inequalities; palliative care; pleural neoplasms; socio-economic position.

MeSH terms

  • Advance Care Planning
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • England
  • Female
  • Humans
  • Male
  • Mesothelioma* / therapy
  • Mesothelioma, Malignant
  • Middle Aged
  • Palliative Care* / standards
  • Palliative Care* / statistics & numerical data
  • Pleural Neoplasms* / mortality
  • Pleural Neoplasms* / therapy
  • Retrospective Studies
  • Terminal Care* / standards
  • Terminal Care* / statistics & numerical data